Related references
Note: Only part of the references are listed.A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M. C. Fargnoli et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M. C. Fargnoli et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Atopic dermatitis in the elderly
S. Williamson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience
S. Ribero et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study
M. Napolitano et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature
Camilla Chello et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis
E. Nettis et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2020)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
C. M. Olesen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis)
Giovanni Damiani et al.
DERMATOLOGIC THERAPY (2019)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Phenotypical Differences of Childhood- and Adult-Onset Atopic Dermatitis
Jonathan I. Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
Thomas Bieber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Clinical Features of Atopic Dermatitis in Adults Are Different according to Onset
Jee Hee Son et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease
Matteo Megna et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
Atopic dermatitis in older adults: A viewpoint from geriatric dermatology
Ryoji Tanei et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Abundant immunoglobulin E-positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderly
R. Tanei et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Effects of age (neonates and elderly) on skin barrier function
Marcia Ramos-e-Silva et al.
CLINICS IN DERMATOLOGY (2012)
Atopic dermatitis in older patients: particular points
A. Katsarou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Adult-onset atopic dermatitis
E Ozkaya
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)